Clinical Trials Browser

Phase 1/2 × Neoplasms × devimistat × Clear all

NCT00907166 2017-03-21

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Phase 1/2 Terminated

Gastrointestinal

Neoplasms, Pancreatic Neoplasms